Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
CRISPR-Cas13 is an RNA editing technique that can manipulate gene expression at the RNA level without modifying the genome. However, the delivery of RNA editors is perhaps the biggest barrier to the widespread adoption of this approach.
The therapeutic delivery of Cas13-based RNA editing systems remains challenging, in part because the size of Cas13-based RNA editors developed so far exceeds the packaging capacity of adeno-associated virus (AAV), the most widely used viral vector for gene delivery.
The therapeutic delivery of Cas13-based RNA editing systems remains challenging, in part because the size of Cas13-based RNA editors developed so far exceeds the packaging capacity of adeno-associated virus (AAV), the most widely used viral vector for gene delivery.
GO Prime with only $1.49 now
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115